Serum macro creatine kinase type 2 as a tumor marker in lung cancer: comparison with carcinoembryonic antigen.

Abstract

Macro creatine kinase type 2 (MCK-2), an atypical cathodically migrating creatine kinase isoenzyme, was first detected in the serum of a breast cancer patient in 1978. In recent years, MCK-2 was also found in the sera of several malignancies and has been proposed as a potential tumor marker. Forty two patients with lung cancer. The rates of MCK-2 presence… (More)

Topics

Cite this paper

@article{Lee1990SerumMC, title={Serum macro creatine kinase type 2 as a tumor marker in lung cancer: comparison with carcinoembryonic antigen.}, author={Y C Gary Lee and K. J. Chang and F. J. Lu and P. C. Yang}, journal={Journal of the Formosan Medical Association = Taiwan yi zhi}, year={1990}, volume={89 2}, pages={104-9} }